logo
Obamacare covers cancer screening and cholesterol meds. Will the Supreme Court change that?

Obamacare covers cancer screening and cholesterol meds. Will the Supreme Court change that?

USA Today19-04-2025

Obamacare covers cancer screening and cholesterol meds. Will the Supreme Court change that? The case focuses on Obamacare's preventative care requirement. Religious opponents say HIV medications, for example, would make them 'complicit in facilitating homosexual behavior."
Show Caption
Hide Caption
Robert F. Kennedy Jr. posts endorsement of measles MMR vaccine on X
Health and Human Services secretary, and vaccine skeptic, Robert F. Kennedy Jr. supports measles vaccine after visiting West Texas.
WASHINGTON − One of the most popular parts of Obamacare - free cancer screenings, cholesterol-lowering medication and diabetes tests - is facing scrutiny in a Supreme Court challenge to the landmark health insurance law that, 15 years in, continues to spark legal battles and political fights.
Two Christian owned businesses and some people in Texas argue that health insurance plans they buy shouldn't have to cover medical tests and drugs they object to on religious grounds. Having to pay for certain HIV-prevention medications, for example, would make them 'complicit in facilitating homosexual behavior,' they've said.
In a twist from the first Trump administration, which tried to kill Barack Obama's landmark health insurance law, Trump's Justice Department will defend the law when the high court takes it up on Monday.
While that shows support across ideological lines, increasing the likelihood that the Supreme Court won't side with the challengers, a victory could give the Trump administration the power to pick and choose the preventive measures it wants to cover and for whom.
'What happens after the case might be more important than how the Supreme Court rules,' said Laurie Sobel, associate director for Women's Health Policy at KFF, a nonpartisan health research organization.
`Folks will notice if this benefit is gone'
The requirement that health insurance plans cover - without copayments or deductibles - services that detect diseases and prevent illnesses from developing has been used by tens of millions of Americans since the 2010 Affordable Care Act became law.
The legal issue at the heart of the Supreme Court Obamacare case is whether one of the three groups of experts that recommends services health insurance must cover is so powerful that, under the Constitution, its members must be appointed by the president and confirmed by the Senate.
If the Supreme Court agrees with the Texas businesses that they are, health insurers would not be required to cover any of the care recommended by the U.S. Preventive Services Task Force after the ACA was enacted. (Other services, such as vaccines, that are recommended by different experts, are in dispute under another aspect of the case that is still in the lower courts.)
For example, in 2021, the task force extended recommendations for colon cancer screening to people 45 and older, instead of 50 and up, because of increased diagnoses in younger people.
'Folks will notice if this benefit is gone or if they're getting charged when they go to the doctor for their preventive care,' said Katie Keith, director of the Center for Health Policy and the Law at the O'Neill Institute for National and Global Health Law.
But if the court agrees with the Trump administration that the task force is controlled by the Health and Human Services Secretary, now Robert F. Kennedy Jr., coverage may also change. Kennedy could fire the task force and appoint members more hospitable to his agenda or impose his own decisions, experts said.
'I think the Trump administration's motivation here is to, as is always the case, to expand the power of the president and the Secretary of HHS,' said Tim Jost, a health law expert and professor emeritus at Washington and Lee University School of Law.
The task force typically updates its recommendations every five years to account for medical advances or reflect new evidence of risk.
Before Obamacare, Americans used preventive services at only about half the recommended rate, according to the federal government.
Obamacare has survived many challenges
The Affordable Care Act, Obama's signature domestic accomplishment, has been the target of more than 2,000 legal challenges and has reached the high court multiple times.
It was upheld in 2012, in 2015 and, most recently, in 2021, when the court dismissed another challenge to the law.
That suit started in the same federal district court in Texas that first heard the latest challenge, which critics say shows opponents of Obamacare were looking for a friendly judge.
U.S. District Judge Reed O'Connor in Texas said the conservativechallengers do not have to cover the HIV-prevention drug PrEP in their insurance plans because it's against their religious beliefs, a decision that is limited to the challengers and that the federal government has not appealed.
But O'Connor also agreed with the businesses that the task force violates the Constitution's appointments clause, which requires presidential appointment and Senate confirmation for officials in significant positions of authority – such as cabinet secretaries and other top agency officials.
The New Orleans-based 5th U.S. Circuit Court of Appeals backed that decision but reversed O'Connor's ruling invalidating the task force's recommendations for anyone but the challengers because of how the case was brought.
The Biden administration asked the Supreme Court to take the case to prevent a nationwide lawsuit, which the court agreed to do shortly before the new administration took office.
Trump administration is defending the law
Unlike an earlier legal challenge to Obamacare when the first Trump administration would not defend the law, the Justice Department in the second Trump administration is arguing the task force doesn't violate the Constitution.
The government says it's the Health and Human Services secretary, and not the task force, that has the 'ultimate responsibility' for whether the experts' recommendations become final. The secretary can deny a recommendation or delay it from going into effect so it can be reconsidered or modified, according to the Justice Department.
The challengers, however, point to a requirement that task force members and their recommendations 'shall be independent and, to the extent practicable, not subject to political pressure.'
'The Secretary does not have the power to remove task force members at will or to deny the recommendations because of the independence requirement,' lawyers for the challengers told the court. 'And even if he did, that would not be enough `direction' and `supervision' authority.'
The government counters that the independence requirement means the task force is supposed to make recommendations based on their impartial medical and public-health judgments.
'It does not mean that the Secretary is barred from then determining whether Task Force recommendations will be given legal effect,' the Justice Department told the Supreme Court.
And if the justices disagrees, they continued, then the court can strike down the 'shall be independent' directive and place the task force fully under the secretary's control.
No matter the outcome, public health advocates expect they will continue to have to fight for coverage of preventive services.
'I think that this is a first example of really testing the waters,' said Dorianne Mason, director of health equity for the National Women's Law Center. 'And I don't think that it will end with this.'

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Can I donate blood and how do I do it? Urgent call for donors amid low stocks
Can I donate blood and how do I do it? Urgent call for donors amid low stocks

Yahoo

time12 minutes ago

  • Yahoo

Can I donate blood and how do I do it? Urgent call for donors amid low stocks

The NHS needs 200,000 more regular blood donors to sustain a safe and sufficient supply. Low blood stocks in 2024 prompted an "amber alert', but blood stocks have remained low ever since. NHS Blood and Transplant (NHSBT) is now urging more people to donate to avoid a "red alert", which is a critical situation where public safety is threatened. It described the past year as "challenging" for blood stocks, noting that just under 800,000 people are supporting the entire blood supply in England. The whole process of giving blood takes just one hour. When arriving at a blood donation centre, you are asked to complete a safety check to make sure you can give blood. You will be given 500ml of fluid to drink – drinking this will help the body maintain blood pressure, prevent dizziness and help the body replenish the donated blood. Then, to ensure it is safe to donate blood, medics will confirm your identity and information in your health check. In some cases, a registered nurse will follow up. A drop of blood from your finger is then checked for iron levels. If these levels are too low, the appointment will be rescheduled. Those able to donate will be seated in the waiting area before being called to a donation chair. Here, a cuff will be placed on your arm to maintain a small amount of pressure during the donation before a suitable vein is found and the area is cleaned. Then, a needle will be inserted into your arm to collect your blood into a blood bag, which has your unique donor number on it. A scale weighs the blood and stops when you have donated 470ml - that's just under a pint. The needle is then removed from your arm, and a dressing is applied. The NHS says the process of giving blood should not hurt and should only take about 10 minutes. Although more donors are needed, there are some health, travel and lifestyle reasons that may stop you from donating blood. Donors need to be fit and well, aged between 17 and 65, weigh between 7 stone 12 Ibs (50kg) and 25 stone (158kg) and have suitable veins. However, you can't donate blood if you have cancer, some heart conditions, have tested positive for HIV or are a hepatitis B or C carrier. If you have received blood platelets, plasma or any other blood products after January 1980, or if you have injected non-prescribed drugs including body-building and injectable tanning agents, you also cannot donate. If you've had anal sex with a new partner in the last three months you may have to postpone your donation. If you feel unwell, are pregnant or have had a baby in the last six months, have had a tattoo or piercing, or have recently travelled to certain countries outside the UK, you may also have to wait before you can donate blood. There are thousands of blood donation venues across England, some are permanent and others are pop-ups. Church halls, sports centres, mosques, football stadiums and hotels are all used as pop-up venues. To check where your closest one is, visit the Give Blood website. You will need to book an appointment ahead of your donation which can be done online as soon as you have signed up as a blood donor. There is a 'critical' need for more donors who have the so-called universal blood type, O negative blood, which is needed for treatment in emergencies. The NHS said there is also a need for more Black donors, who are more likely to have specific blood types which can help treat people with sickle cell disease.

NIH scientists condemn Trump research cuts
NIH scientists condemn Trump research cuts

Yahoo

time19 minutes ago

  • Yahoo

NIH scientists condemn Trump research cuts

Hundreds of staffers from across the National Institutes of Health (NIH) are speaking out against the politicization of their research and termination of their work while demanding that the drastic changes made at the agency be walked back. In a letter addressed to NIH Director Jay Bhattacharya, more than 2,000 signatories stated, 'we dissent to Administration policies that undermine the NIH mission, waste public resources, and harm the health of Americans and people across the globe.' The letter was titled 'The Bethesda Declaration' in reference to where NIH's campus is located. The signatories cited Bhattacharya's stated commitment to academic freedom that he made in April and called on him to push back against the changes Trump administration has implemented at NIH under his leadership. 'Academic freedom should not be applied selectively based on political ideology. To achieve political aims, NIH has targeted multiple universities with indiscriminate grant terminations, payment freezes for ongoing research, and blanket holds on awards regardless of the quality, progress, or impact of the science,' they wrote. They pointed to U.S. law and prior research that has shown that the participation of diverse populations in studies is necessary for NIH's work. The NIH staffers further blasted the canceling of nearly completed studies. 'Ending a $5 million research study when it is 80% complete does not save $1 million, it wastes $4 million,' they wrote. The researchers called on Bhattacharya to restore foreign collaborations with the global scientific community, put independent peer reviews back in place, bring back terminated NIH staffers and rethink the 15 percent cap on indirect study costs that the Trump administration enacted. 'Combined, these actions have resulted in an unprecedented reduction in NIH spending that does not reflect efficiency but rather a dramatic reduction in life-saving research,' they stated. 'Some may use the false impression that NIH funding is not needed to justify the draconian cuts proposed in the President's Budget. This spending slowdown reflects a failure of your legal duty to use congressionally-appropriated funds for critical NIH research.' NIH research is not solely centered in Bethesda. The agency is responsible for funding research projects across the country and abroad. Numerous lawsuits have been filed to combat the pulling back of billions of dollars in NIH funding. Last week, a federal judge allowed a suit filed by university researchers and public health groups challenging the cuts to move forward. Bhattacharya responded to the letter on the social media platform X. 'We all want @NIH to succeed and I believe that dissent in science is productive. However, the Bethesda Declaration has some fundamental misconceptions about the policy directions NIH has taken in recent months,' he wrote. Bhattacharya said the actions taken at NIH have been to 'remove ideological influence from science' and further argued the agency hasn't halted international scientific collaboration but is instead 'ensuring accountability.' 'Claims that NIH is undermining peer review are misunderstood. We're expanding access to publishing while strengthening transparency, rigor, and reproducibility in NIH-funded research,' he wrote. 'Lastly, we are reviewing each termination case carefully and some individuals have already been reinstated. As NIH priorities evolve, so must our staffing to stay mission-focused and responsibly manage taxpayer dollars.' Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Why Universal Health Services (UHS) Shares Are Trading Lower Today
Why Universal Health Services (UHS) Shares Are Trading Lower Today

Yahoo

time29 minutes ago

  • Yahoo

Why Universal Health Services (UHS) Shares Are Trading Lower Today

Shares of hospital management company Universal Health Services (NYSE:UHS) fell 5.7% in the afternoon session after Chief Financial Officer Steve Filton noted during a recent conference that procedural volumes (an important driver of hospital revenue) "have been slower to recover back to historical levels than we might have imagined." Filton also voiced concern over the Trump administration's proposed federal spending bill, particularly its implications for healthcare funding. Since UHS derives a significant portion of its revenue from government programs like Medicare and Medicaid, the anticipated cuts to Medicaid could significantly affect the company, especially in regions with high dependency on public healthcare funding. The shares closed the day at $177.76, down 6.2% from previous close. The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Is now the time to buy Universal Health Services? Access our full analysis report here, it's free. Universal Health Services's shares are not very volatile and have only had 8 moves greater than 5% over the last year. In that context, today's move indicates the market considers this news meaningful, although it might not be something that would fundamentally change its perception of the business. The previous big move we wrote about was 28 days ago when the stock gained 5.9% after the major indices popped (Nasdaq +3.4%, S&P 500 +2.5%) in response to the positive outcome of U.S.-China trade negotiations, as both sides agreed to pause some tariffs for 90 days, signaling a potential turning point in ongoing tensions. This rollback cuts U.S. tariffs on Chinese goods to 30% and Chinese tariffs on U.S. imports to 10%, giving companies breathing room to reset inventories and supply chains. However, President Trump clarified that tariffs could go "substantially higher" if a full deal with China wasn't reached during the 90-day pause, but not all the way back to the previous levels. Still, the agreement has cooled fears of a prolonged trade war, helping stabilize expectations for global growth and trade flows and fueling renewed optimism. The optimism appeared concentrated in key trade-sensitive sectors, particularly technology, retail, and industrials, as lower tariffs reduce cost pressures and restore cross-border demand. Universal Health Services is down 1.1% since the beginning of the year, and at $177.77 per share, it is trading 26.4% below its 52-week high of $241.52 from September 2024. Investors who bought $1,000 worth of Universal Health Services's shares 5 years ago would now be looking at an investment worth $1,628. Unless you've been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store